Tesla in the waiting room as revenue slidesTesla, Inc.BATS:TSLABlueberryTesla is a global innovator that is changing the world. As a general rule, many investors have a saying: Never bet against Elon. They're not wrong. Elon delivers. But the short term is messy. The stock is hovering around its 200-day moving average, a critical test. Break lower and we could see $290, maybe $260. That’s not panic, it's just price catching up to reality. The auto business is deep in a downcycle. Q2 deliveries fell 14%, with revenue down 12%. Profits squeezed. Classic cyclical move. Nothing new here. But it’s weighing on momentum. The upside isn’t about cars, it's autonomy, robotaxis, AI (Grok in cars). That’s where Tesla becomes a $2 trillion company. Musk knows it and is building for the future (100,000 GPU super cluster). He’s already shifting the story. But that future is 6–12 months out, maybe longer. In the meantime, we sit in the waiting room. Auto volumes need to stabilise. Robotaxi needs scale. Optimus requires proof and some definitive timeframes to get the market excited. That creates a 3–6 month narrative gap. Markets hate gaps. Earnings last week were among the softest (though expected). EPS fell 23%. Free cash flow almost vanished. No real catalysts until next quarter. If the broader market sells off, which looks likely, Tesla takes more heat. But let’s not lose the plot. Tesla is still Tesla. Long-term vision remains. Musk’s execution record is unmatched. Bet against him and you lose, eventually. Short term, expect weakness. Patience required. If the stock breaks $315 with conviction, we’d expect further weakness before the real upside re-emerges. Wait, watch, then pounce. The forecasts provided herein are intended for informational purposes only and should not be construed as guarantees of future performance. This is an example only to enhance a consumer's understanding of the strategy being described above and is not to be taken as Blueberry Markets providing personal advice.